Advertisement · 728 × 90
#
Hashtag
#IM_Cannabis
Advertisement · 728 × 90
Preview
IM Cannabis Corp. Receives Nasdaq Minimum Bid Price Notification Amidst Growth and Challenges IM Cannabis Corp. received a notice from Nasdaq regarding its minimum bid price, granting it 180 days to comply while continuing operations in Israel and Germany.

IM Cannabis Corp. Receives Nasdaq Minimum Bid Price Notification Amidst Growth and Challenges #NASDAQ #Canada #Toronto #cannabis_industry #IM_Cannabis

0 0 0 0
Preview
IM Cannabis Corp's 2025 Financial Report Reveals Major Growth in Germany and Positive Cash Flow IM Cannabis Corp announces impressive 2025 results, highlighting significant revenue growth in Germany and achieving positive operating cash flow, marking a successful turnaround for the company.

IM Cannabis Corp's 2025 Financial Report Reveals Major Growth in Germany and Positive Cash Flow #medical_cannabis #IM_Cannabis #Germany_growth

0 0 0 0
Preview
IM Cannabis Corp. Expands Into Defense Technology with Acquisition Plans IM Cannabis Corp. has announced plans to acquire 51% of Blackaxe Technologies, marking its entry into defense and homeland security sectors.

IM Cannabis Corp. Expands Into Defense Technology with Acquisition Plans #USA #Toronto #Defense_Technology #IM_Cannabis #Blackaxe_Tech

0 0 0 0
Preview
IM Cannabis Secures Over $2 Million in Financing for Growth and Stability IM Cannabis Corp announced the raising of $2.17 million through note purchase agreements, enhancing liquidity and reducing liabilities.

IM Cannabis Secures Over $2 Million in Financing for Growth and Stability #USA #Toronto #medical_cannabis #IM_Cannabis #Note_Purchase_Agreements

0 0 0 0
Preview
IM Cannabis Expands Leadership with Appointment of Alon Dayan to Board IM Cannabis Corp. recently appointed Alon Dayan to its Board of Directors, enhancing its leadership with his extensive experience in the tech and security sectors.

IM Cannabis Expands Leadership with Appointment of Alon Dayan to Board #Israel #Toronto #medical_cannabis #IM_Cannabis #Alon_Dayan

0 0 0 0
Preview
IM Cannabis Eyes U.S. Market Following Trump's Executive Order on Medical Marijuana IM Cannabis Corp. is actively seeking entry into the U.S. market, following President Trump's recent executive order aimed at increasing medical marijuana research and easing regulations.

IM Cannabis Eyes U.S. Market Following Trump's Executive Order on Medical Marijuana #USA #Toronto #medical_cannabis #U.S._Market #IM_Cannabis

0 0 0 0
Preview
IM Cannabis Announces Asi Levi as New CFO to Enhance Financial Direction IM Cannabis Corp. has appointed Asi Levi as the new Chief Financial Officer, aiming to strengthen its financial strategy and operations.

IM Cannabis Announces Asi Levi as New CFO to Enhance Financial Direction #Canada #CFO #Toronto #IM_Cannabis #Asi_Levi

0 0 0 0
Preview
IM Cannabis Corp. Reveals Third Quarter 2025 Financial Performance Insights IM Cannabis Corp. shares its financial results for Q3 and the first nine months of 2025. Key highlights include revenue stability and reduced gross profit.

IM Cannabis Corp. Reveals Third Quarter 2025 Financial Performance Insights #Canada #Toronto #cannabis_industry #IM_Cannabis #Nasdaq_IMCC

0 0 0 0
Preview
IM Cannabis Corp. Scheduled to Announce Q3 2025 Financial Results on November 13th IM Cannabis Corp. will release its financial performance results for the third quarter of 2025 on November 13, providing insights into its operations in Israel and Germany.

IM Cannabis Corp. Scheduled to Announce Q3 2025 Financial Results on November 13th #Israel #earnings_report #medical_cannabis #IM_Cannabis #Glil_Yam

0 0 0 0
Preview
IM Cannabis Announces Departure of CFO Uri Birenberg in Transition Phase IM Cannabis Corp. reveals the resignation of its Chief Financial Officer, Uri Birenberg, as it prepares for a structured transition. Birenberg will remain until January 2026.

IM Cannabis Announces Departure of CFO Uri Birenberg in Transition Phase #USA #Toronto #CFO_Transition #IM_Cannabis #Uri_Birenberg

0 0 0 0
Preview
IM Cannabis Expands Bio Data Capabilities with Major Quantum Computing Acquisition IM Cannabis Corp. takes a bold step by signing a non-binding term sheet to acquire a 60% stake in a quantum computing bio data company for up to $54 million.

IM Cannabis Expands Bio Data Capabilities with Major Quantum Computing Acquisition #Canada #Quantum_Computing #Toronto #IM_Cannabis #Bio_Data

0 0 0 0
Preview
IM Cannabis Corp. Announces Board Restructuring and New Business Strategy Exploration IM Cannabis Corp. recently announced board changes and is exploring new business opportunities to enhance growth and shareholder value.

IM Cannabis Corp. Announces Board Restructuring and New Business Strategy Exploration #Canada #Toronto #IM_Cannabis #Shmulik_Arbel #Eli_Zamir

0 0 0 0
Preview
IM Cannabis Successfully Regains Nasdaq Compliance for Stockholders' Equity Requirement IM Cannabis Corp. recently announced that it has successfully regained compliance with Nasdaq's stockholders' equity requirements, allowing its shares to continue trading.

IM Cannabis Successfully Regains Nasdaq Compliance for Stockholders' Equity Requirement #USA #Toronto #IM_Cannabis #Nasdaq_IMCC #Israeli_cannabis

0 0 0 0
Preview
IM Cannabis Reveals Warrant Amendment and SEC Filing Details IM Cannabis Corp. has announced significant warrant amendments and filed a resale registration statement with the SEC, marking a new chapter in its operations.

IM Cannabis Reveals Warrant Amendment and SEC Filing Details #Canada #Toronto #SEC_Filing #IM_Cannabis #Warrant_Amendments

0 0 0 0
Preview
IM Cannabis Corporation Demonstrates Strong Financial Resilience Amid Revenue Challenges in Q2 2025 In Q2 2025, IM Cannabis Corp. increased gross profits by 306% despite a 14% revenue drop due to external factors. Explore their strategic growth.

IM Cannabis Corporation Demonstrates Strong Financial Resilience Amid Revenue Challenges in Q2 2025 #USA #Toronto #medical_cannabis #IM_Cannabis #profitability_growth

0 0 0 0
Preview
IM Cannabis Corp. to Unveil Financial Results for Q2 2025 on August 12 IM Cannabis Corp. is set to announce its financial results for the second quarter of 2025 on August 12th, highlighting its operations in Israel and Germany.

IM Cannabis Corp. to Unveil Financial Results for Q2 2025 on August 12 #None #Israel #medical_cannabis #IM_Cannabis

0 0 0 0
Preview
IM Cannabis Successfully Completes Private Placement Raising Approximately $4.1 Million IM Cannabis Corp. has successfully closed a private placement offering, generating about $4.1 million for its operations in the medical cannabis sector.

IM Cannabis Successfully Completes Private Placement Raising Approximately $4.1 Million #Canada #Toronto #fundraising #medical_cannabis #IM_Cannabis

0 0 0 0
Preview
IM Cannabis Expands Leadership and Secures $2 Million Loan Agreement IM Cannabis Corp. enhances its leadership team with Oz Adler's appointment and secures important funding through a loan agreement.

IM Cannabis Expands Leadership and Secures $2 Million Loan Agreement #Canada #Toronto #IM_Cannabis #loan_agreement #Oz_Adler

0 0 0 0
Preview
IM Cannabis Corp. Updates Stakeholders on Nasdaq Compliance and Future Plans IM Cannabis Corp. discusses recent updates regarding compliance with Nasdaq requirements, aiming to ensure the company's presence on the exchange by October 2025.

IM Cannabis Corp. Updates Stakeholders on Nasdaq Compliance and Future Plans #USA #NASDAQ #Toronto #Compliance #IM_Cannabis

0 0 0 0
Preview
IM Cannabis Corp. Announces Intent to Voluntarily Delist from CSE to Streamline Operations IM Cannabis Corp. is set to delist its shares from the Canadian Securities Exchange, transitioning fully to NASDAQ to optimize operations and enhance shareholder value.

IM Cannabis Corp. Announces Intent to Voluntarily Delist from CSE to Streamline Operations #None #NASDAQ #IM_Cannabis #CSE

0 0 0 0
Preview
IM Cannabis Corp. Reports Significant Corporate Developments and Financial Restructuring Strategies IM Cannabis has announced key corporate updates, including voting results from its annual meeting, significant financial decisions, and restructuring plans aimed at enhancing growth and profitability.

IM Cannabis Corp. Reports Significant Corporate Developments and Financial Restructuring Strategies #Canada #Israel #Toronto #medical_cannabis #IM_Cannabis

0 0 0 0
Preview
IM Cannabis Corp. Reports Positive Financial Performance in Q1 2025 IM Cannabis Corp. announced impressive financial results for Q1 2025, including a net profit and a significant improvement in gross margins, reflecting effective operational strategies.

IM Cannabis Corp. Reports Positive Financial Performance in Q1 2025 #Canada #Toronto #medical_cannabis #Q1_2025 #IM_Cannabis

0 0 0 0
Preview
IM Cannabis Files Information Circular for Shareholder Meeting Scheduled in May 2025 IM Cannabis Corp. announces the filing of its management information circular for the upcoming shareholder meeting. Key details about upcoming transactions are shared.

IM Cannabis Files Information Circular for Shareholder Meeting Scheduled in May 2025 #Canada #Toronto #shareholder_meeting #IM_Cannabis #Focus_Transaction

0 0 0 0
Preview
IM Cannabis Corp. Posts Corporate Developments Amid Regulatory Compliance Challenges IM Cannabis Corp. announces recent corporate updates, including compliance issues with Nasdaq and plans to acquire Focus Medical Herbs Ltd. for strategic growth.

IM Cannabis Corp. Posts Corporate Developments Amid Regulatory Compliance Challenges #NASDAQ #Canada #Toronto #IM_Cannabis #Focus_Medical

1 0 0 0
Preview
IM Cannabis Reports Robust Financial Results for Q4 and Full Year 2024 With Notable Revenue Growth and Decreased Expenses IM Cannabis Corp. reveals strong financial data for Q4 2024, including 25% revenue growth and significant improvements in operational efficiency, marking a turnaround year.

IM Cannabis Reports Robust Financial Results for Q4 and Full Year 2024 With Notable Revenue Growth and Decreased Expenses #None #financial_results #medical_cannabis #IM_Cannabis

0 0 0 0